Antihistamine (Unknown)

Verify with FDA CVM →

129 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
129
Total Reports
4
Deaths Reported
310.0%
Death Rate

Active Ingredients

Antihistamine (Unknown)

Administration Routes

OralUnknownIntramuscularSubcutaneousParenteral

Species Affected

Dog 122
Cat 3
Human 2
Cattle 1
Unknown 1

Most Affected Breeds

Chihuahua 10
Shih Tzu 8
Crossbred Canine/dog 7
Retriever - Labrador 7
Retriever - Golden 6
Bichon Frise 5
Beagle 5
Bulldog 4
Boxer (German Boxer) 4
Schnauzer - Miniature 4

Most Reported Reactions

Emesis 50
Vomiting 17
Lethargy (see also Central nervous system depression in 'Neurological') 15
Lack of efficacy (ectoparasite) - flea 11
Lack of efficacy - NOS 9
Other abnormal test result NOS 9
Diarrhoea 6
Elevated alanine aminotransferase (ALT) 6
Cough 4
Neutrophilia 4
Scratching 4
Seizure NOS 4

Outcome Breakdown

Recovered/Normal
67 (52.3%)
Outcome Unknown
39 (30.5%)
Recovered with Sequela
13 (10.2%)
Ongoing
5 (3.9%)
Died
3 (2.3%)
Euthanized
1 (0.8%)

Data Summary

Metric Value
Total adverse event reports 129
Reports involving death 4
Case-fatality rate (reported events) 310.0%
Distinct species in reports 5
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Antihistamine (Unknown) Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 129 adverse event reports referencing Antihistamine (Unknown), including 4 reports in which the animal died — a 310.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Antihistamine (Unknown). Reported administration routes include Oral, Unknown, Intramuscular, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Antihistamine (Unknown) reports are Dog (122 reports), Cat (3 reports), Human (2 reports), with Dog accounting for the largest share. Within those species, Chihuahua (10), Shih Tzu (8), Crossbred Canine/dog (7) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Antihistamine (Unknown) are Emesis (50), Vomiting (17), Lethargy (see also Central nervous system depression in 'Neurological') (15), Lack of efficacy (ectoparasite) - flea (11). Of the 128 reports with a coded outcome, Recovered/Normal is the leading category at 52.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Antihistamine (Unknown).

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial